These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 347806

  • 21. [Guanfacine in primary arterial hypertension: a long-term open clinical study].
    Román O, Valenzuela MA, Salazar R.
    Rev Med Chil; 1982 Dec; 110(12):1179-84. PubMed ID: 6764015
    [No Abstract] [Full Text] [Related]

  • 22. Hypotensive effect of guanfacine in essential hypertension: a comparison with clonidine.
    Lauro R, Reda G, Spallone L, Anguissola AB.
    Br J Clin Pharmacol; 1980 Dec; 10 Suppl 1(Suppl 1):81S-82S. PubMed ID: 6994784
    [No Abstract] [Full Text] [Related]

  • 23. Comparison of sustained-release and standard preparations of clonidine in essential hypertension.
    Fyhrquist F.
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):634-6. PubMed ID: 6365808
    [Abstract] [Full Text] [Related]

  • 24. The effect of small doses of guanfacine (Estulic Sandoz) on the lipid levels and catecholamine excretion in patients with essential hypertension.
    Balazovjech I, Skultétyová D, Mikulecký M, Kratochvíl'ová H.
    Cor Vasa; 1987 Dec; 29(4 Suppl 1):46-52. PubMed ID: 3315451
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. [Guanfacine versus alpha-methyldopa in benign essential hypertension. An ambulatory group study].
    Rhomberg F, Widler J.
    Schweiz Med Wochenschr; 1981 Dec 12; 111(50):1967-8. PubMed ID: 7036334
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Guanfacine in the treatment of hypertension: two years' experience with low dose monotherapy.
    Jerie P, Lasance A.
    Int J Clin Pharmacol Ther Toxicol; 1981 Jun 12; 19(6):279-87. PubMed ID: 7030975
    [Abstract] [Full Text] [Related]

  • 29. Clinical dose-response studies with guanfacine (BS 100-141), a new antihypertensive agent.
    MacCarthy P, Isaac P, Frost G, Freeman A, Stokes G.
    Clin Exp Pharmacol Physiol; 1978 Jun 12; 5(2):187-90. PubMed ID: 348364
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. A postmarketing evaluation of guanfacine hydrochloride in mild to moderate hypertension.
    Board AW, Perry VP, Shepperson BE, Nyman CE, Carchman SH.
    Clin Ther; 1988 Jun 12; 10(6):761-75. PubMed ID: 3064907
    [Abstract] [Full Text] [Related]

  • 33. [Clofelin therapy of hypertensive crises].
    Danilov LN.
    Klin Med (Mosk); 1981 Mar 12; 59(3):34-5. PubMed ID: 7265828
    [No Abstract] [Full Text] [Related]

  • 34. A double-blind comparison of transdermal clonidine and oral captopril in essential hypertension.
    McMahon FG, Jain AK, Vargas R, Fillingim J.
    Clin Ther; 1990 Mar 12; 12(2):88-100. PubMed ID: 2191779
    [Abstract] [Full Text] [Related]

  • 35. Guanfacine: a new centrally-acting antihypertensive agent.
    Beevers DG, Bloxham CA, Walker JM.
    Pharmatherapeutica; 1981 Mar 12; 2(8):513-6. PubMed ID: 7019931
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Clinical pharmacology of centrally acting antihypertensive agents.
    Weber MA.
    J Clin Pharmacol; 1989 Jul 12; 29(7):598-602. PubMed ID: 2668350
    [Abstract] [Full Text] [Related]

  • 39. Clonidine and guanfacine in hypertension.
    Jain AK, Hiremath A, Michael R, Ryan JR, McMahon FG.
    Clin Pharmacol Ther; 1985 Mar 12; 37(3):271-6. PubMed ID: 3882307
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.